Diese Website verwendet Cookies, damit wir dir die bestmögliche Benutzererfahrung bieten können. Cookie-Informationen werden in deinem Browser gespeichert und führen Funktionen aus, wie das Wiedererkennen von dir, wenn du auf unsere Website zurückkehrst, und hilft unserem Team zu verstehen, welche Abschnitte der Website für dich am interessantesten und nützlichsten sind.
News
9 Mrz 2023 Ibex and Alverno Laboratories sign multi-year, multi-tissue expansion agreement of AI for cancer diagnosis
Read more
7 Mrz 2023 Ibex secures PathLAKE contracts to roll out AI-based cancer diagnostics to UK hospitals
Read more
6 Mrz 2023 Ibex scoops second win of the UK Artificial Intelligence Award with leading NHS trusts
Read more
9 Feb 2023 Ibex’s prostate solution becomes first standalone AI-powered cancer diagnostics solution to obtain CE mark under the IVDR
Read more
24 Jan 2023 Ibex Medical Analytics Enters Collaboration with AstraZeneca and Daiichi Sankyo to Develop AI-based HER2 Scoring Product
Read more
21 Dez 2022 Institut Curie study published in a Nature Journal reporting excellent outcomes of Ibex’s AI solution for breast cancer detection
Read more
7 Dez 2022 Leading UK diagnostics provider source LDPath expands AI capabilities with Ibex Medical Analytics
Read more
4 Sep 2022 Ibex announces version 3.0, of it’s AI platform, a transformative cancer diagnostics platform offering new detection capabilities and a broad feature set
Read more
2 Sep 2022 Ibex and Medipath sign multi-year, multi-site and multi-tissue expansion of AI for cancer diagnosis across France
Read more